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Abstract
Bone marrow derived mesenchymal stem cells (BM-MSCs) have been shown to enhance wound healing; however, the
mechanisms involved are barely understood. In this study, we examined paracrine factors released by BM-MSCs and their
effects on the cells participating in wound healing compared to those released by dermal fibroblasts. Analyses of BM-MSCs
with Real-Time PCR and of BM-MSC-conditioned medium by antibody-based protein array and ELISA indicated that BM-
MSCs secreted distinctively different cytokines and chemokines, such as greater amounts of VEGF-a, IGF-1, EGF, keratinocyte
growth factor, angiopoietin-1, stromal derived factor-1, macrophage inflammatory protein-1alpha and beta and
erythropoietin, compared to dermal fibroblasts. These molecules are known to be important in normal wound healing.
BM-MSC-conditioned medium significantly enhanced migration of macrophages, keratinocytes and endothelial cells and
proliferation of keratinocytes and endothelial cells compared to fibroblast-conditioned medium. Moreover, in a mouse
model of excisional wound healing, where concentrated BM-MSC-conditioned medium was applied, accelerated wound
healing occurred compared to administration of pre-conditioned or fibroblast-conditioned medium. Analysis of cell
suspensions derived from the wound by FACS showed that wounds treated with BM-MSC-conditioned medium had
increased proportions of CD4/80-postive macrophages and Flk-1-, CD34- or c-kit-positive endothelial (progenitor) cells
compared to wounds treated with pre-conditioned medium or fibroblast-conditioned medium. Consistent with the above
findings, immunohistochemical analysis of wound sections showed that wounds treated with BM-MSC-conditioned medium
had increased abundance of macrophages. Our results suggest that factors released by BM-MSCs recruit macrophages and
endothelial lineage cells into the wound thus enhancing wound healing.
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Introduction
Optimum healing of a cutaneous wound requires a well-
orchestrated integration of the complex biological and molecular
events of cell migration and proliferation, extracellular matrix
(ECM) deposition, angiogenesis and remodeling [1–3]. Impair-
ment in this orderly progression of the healing process may lead to
chronic wounds which often occur in individuals with chronic
conditions such as diabetes. Of over150 million people with
diabetes, 15% suffer from chronic wounds [3,4]. Among the many
factors contributing to (non-healing) chronic wounds, impairment
in the production of cytokines by local inflammatory cells and
fibroblasts and reduced angiogenesis are crucial [3].
Bone marrow derived mesenchymal stem cells (BM-MSCs),
which are also referred to as multipotent stromal progenitor cells
[5], have been shown to promote tissue repair in numerous
studies. Transplantation of ex vivo expanded BM-MSCs improves
repair to the infarcted heart [6] and brain [7] in animals.
Allogeneic BM-MSCs derived from healthy donors have been
used to treat diseases in humans [8]. In our previous study, we
found that implantation of BM-MSCs enhanced wound healing in
non-diabetic and diabetic mice; however, the underlying mech-
anisms have not been fully understood. As the major stromal cells
in the bone marrow, BM-MSCs have been known to release
factors such as erythropoietin (EPO) and granulocyte colony-
stimulating factor (G-CSF) supporting the survival, proliferation
and differentiation of hematopoietic stem/progenitor cells.
Interestingly, many of these factors have recently been shown to
enhance repair/regeneration of non-hematopoietic tissues [9,10].
On the other hand, fibroblasts are the major stromal cells in the
connective tissue. They are known to release cytokines and ECM
molecules modulating parenchymal cells and scar healing to
injured tissues. Moreover, fibroblasts have been used clinically in
patients to treat diabetic or venous skin ulcers, but the benefit
remains controversial [11,12].
In this study, we compared the levels of paracrine factors
secreted by BM-MSCs and dermal fibroblasts and their influences
on cell recruitment and wound repair. Our analysis using Real-
Time PCR, antibody-based protein array and ELISA showed
distinctively different expression levels of numerous cytokines and
chemokines between these two types of stromal cells. In addition,
MSC-conditioned medium exhibited greater effect in mediating
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+ monocytes, keratinocytes and endothelial cells
and proliferation of keratinocytes and endothelial cells. Moreover,
application of concentrated MSC-conditioned medium accelerat-
ed wound healing compared to administration of pre-conditioned
or fibroblast-conditioned medium. Analysis of cells in the wound
by FACS and immunohistochemistry revealed that MSC-condi-
tioned medium increased recruitment of macrophages and
endothelial/progenitor cells into the wound, implying beneficial
paracrine effect of BM-MSCs in wound healing.
Methods
All animal procedures were approved under the guidelines of
the Health Sciences Animal Policy and Welfare Committee of the
University of Alberta.
Isolation, purification and characterization of MSCs
The bone marrow was collected from the femurs and tibia of 5–
7 week-old male Balb/C mice (Jackson Laboratory) and nucleated
cells were isolated with a Ficoll-paque density gradient. The
nucleated cells were plated in plastic tissue culture dishes and
incubated in minimal essential medium (a-MEM; GIBCO)
supplemented with 17% fetal bovine serum (FBS). When reaching
80% confluent, the adherent cells were harvested and subjected to
immunodepletion using antibody-coated magnetic micro beads
(Miltenyi Biotec) against CD34, CD14, Gr-1, CD3 and CD19.
Characterization of the cells for their immunophenotypic markers
by fluorescent-activated cell sorting (FACS) showed that they were
negative for cell lineage markers CD45, CD14, CD34, CD19,
CD3, Flk-1 and positive for typical MSC surface proteins Sca-1,
CD105, CD29, CD90, CD73 and CD44 (Table 1). Monoclonal
antibodies conjugated with fluorescein isothiocyanate (FITC) or
phycoerythrin (PE) were used for the analysis and all antibodies
were purchased from BD Pharmingen except for CD34 and CD73
which were obtained from eBioscience. After culturing in
induction media [13,14], the cells differentiated into adipocytes,
osteoblasts and chodrocytes. Human BM-MSCs were purchased
from CAMBREX . Passage 3–5 murine and human BM-MSCs
were used for the experiments.
Isolation of cells from the skin
Keratinocytes were isolated from neonatal Balb/C mouse skin
using methods previously described [15]. In brief, the skin was
incubated with Dispase I (Sigma) in keratinocyte-SFM (Gibco) at
10 mg/ml for 13 hours at 4uC. After separation from the dermis,
the epidermis was trypsinized (0.25% trypsin/0.1%EDTA) for
10 minutes. Cells were seeded on plastic tissue culture plates in
keratinocyte-SFM supplemented with 10 ng/ml EGF and
10
210 M choleratoxin. Fibroblasts were obtained from the dermis
of neonatal Balb/C mice after digestion with 0.75% collagenase
and cultured in DMEM supplemented with 10% FBS. Human
fibroblasts were isolated from human foreskins and cultured as
previously described [16]. Passage 3–5 murine and human
fibroblasts were used for the experiments. Profiling of cell surface
proteins by FACS showed that the cells exhibited typical markers
of fibroblasts (Table 1).
Flow cytometry
Excised wounds together with a small amount of the
surrounding skin were dispersed enzymatically into single cell
suspensions as previously described [17]. In brief, the tissue was
incubated with dispase I (Sigma) at 1 mg/ml overnight at 4uC,
minced and incubated in a digestion buffer containing hyaluron-
idase (1 mg/ml), collagenase D (1 mg/ml) and DNAase (150
units/ml) in a 37uC shaking water bath for 2 hours. The dispase
and the hyaluronidase digests were pooled and filtered through a
70 um Nylon cell strainer. Cells were washed, pelleted, resus-
pended in PBS containing 3% FBS at 10
6/mL. 100 mL cell
aliquots were first blocked with Mouse BD Fc Block and then
incubated with FITC- or PE-conjugated monoclonal antibodies
specific for CD45, CD14, CD3, CD8a, CD19, CD34
(eBioscience), CD11b, Flk-1, or control isotype IgG on ice for
30 minutes. After washing with PBS, the samples were analyzed
by flow cytometry (Becton Dickinson) using Cell Quest software.
All antibodies except that with indication were purchased from BD
Pharmingen.
Conditioned medium
Conditioned medium was generated as follows: 80% confluent
passage 3 BM-MSCs or neonatal dermal fibroblasts in 10 cm-
tissue culture dishes were fed with 5 ml per dish of serum-free a-
MEM or other media as indicated and incubated for 24 h under
hypoxic conditions (5% CO2, 95% N2, and 0.5% O2) in a hypoxic
chamber. For in vivo experiments, the conditioned medium was
further concentrated (50 times) by ultrafiltration using centrifugal
filter units with 5 kDa cut-off (Millipore) following manufacturer’s
instructions.
Cell proliferation
Equal numbers of murine dermal keratinocytes or human
umbilical vein endothelial cells (HUVECs, CAMBREX) were
seeded in 12-well tissue culture plates in vehicle-, fibroblast- or
MSC-conditioned medium or control medium as indicated and
incubated for various times. Media were changed once at day 4.
Cells were detached and counted at times as indicated.
Cell migration
Cell transwell migration assay was performed [18] where
0.5610
5 keratinocytes or HUVECs per well in 100 ml medium
were added to the top chambers of 24-well transwell plates
(8.0 mm, pore size; Costar). 600 ml MSC- or fibroblast (FB)-
conditioned medium or vehicle control medium was added to the
lower chambers. Cells were maintained at 37uC for 8 (HUVECs)
or 15 (keratinocytes) hours. Cells on the upper side of the filter
were wiped out and cells on the bottom side of the filter (migrated)
were fixed with paraformaldehyde (PFA), stained with Hoechst to






CD90 (Thy-1) ++++ ++++
CD44 ++++ ++++
CD73 (SH4, ecto-59-nucleosidase) ++++ ++++
CD105 (SH2, endoglin) +++ ++++
Sca-1 (Ly-6A/E) 2/+ ++++
Representative results of three FACS analyses of murine dermal fibroblasts and
BM-MSCs. 2 , ++++ represent percentages of cells expressing surface markers
as indicated: ‘‘2’’ # 2%; ‘‘+’’ 3,10%; ‘‘++’’ 11,50%; ‘‘+++’’ 51,90%; ‘‘++++’’
91,100%.
doi:10.1371/journal.pone.0001886.t001
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per well were counted. The CD14
+ monocytes were isolated from
human peripheral blood mononuclear cells (PBMCs) using CD14
MicroBeads (Miltenyi Biotec) [19]. Human PBMCs were isolated
by density gradient centrifugation with Ficoll-Hypaque. Flow
cytometric analysis showed that the purity of the CD14
+ cells was
more than 95%. Transwell migration of CD14
+manocytes was
performed as previously described [19]. Briefly, 2610
5 CD14
+ma-
nocytes per well in 100 ml medium were added to the top
chambers of 24-well transwell plates (5.0 mm, pore size; Costar)
and 600 ml MSC- or fibroblast (FB)-conditioned RPMI1640 or
vehicle control medium was added to the lower chambers. After
2 hours of incubation at 37uC with 5% CO2, cells that migrated to
the lower chamber were collected and counted.
Real-Time PCR analysis
Total RNA was extracted (RNeasy Mini Kit, Qiagen) from
cultured BM-MSCs or neonatal dermal fibroblasts which were
80% confluent and had been treated under hypoxic conditions for
8 h, and reverse transcribed using SuperScript First-Strand
Synthesis kit (RT-PCR; Invitrogen). The primers used for Real-
Time PCR are shown in Table 2. Reactions were performed using
SYBR-Green PCR master mix (Applied Biosystems) in a BioRad
iCycler iQ Detection System. As an internal control, levels of
glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) were quan-
tified in parallel with target genes. Normalization and fold changes
were calculated using the DDCt method [20].
Antibody-based protein array and ELISA
The assay was performed following the manufacturer’s
instructions (Chemicon). Briefly, samples containing equal
amounts of total proteins were incubated with antibody mem-
branes. After washing, the membranes were incubated with biotin-
conjugated anti-cytokines primary antibodies followed by washes
and incubation with HRP-conjugated streptavidin. Chemilumi-
nescence was used for signal detection. Staining intensity of dots
were determined with Quantity One image analysis software
(Molecular Imager FX, Bio-Rad Laboratories) and graded into +
, ++++. Enzyme-Linked ImmunoSorbent Assay (ELISA) analyses
for IGF-1, KGF, EPO, TPO and MIP-1a (R&D) were performed
following the manufacturer’s instructions.
Wound healing model
Balb/Cmice(8 week-old,female,bodyweight20–23grams)were
obtained from Jackson Laboratory. The animals were randomly
divided into three groups and the excisional wound splinting model
was generated as described previously [21]. In brief, after hair
removal from the dorsal surface and anesthesia, two 6-mm full-
thickness excisional skin wounds were created on each side of the
midline. Each wound received 100 ml of pre-conditioned medium or
concentrated fibroblast- or MSC-conditioned medium (80 mlf o r
subcutaneous injection around the wound and 20 mlf o rt o p i c a l
application on the wound bed). A donut-shaped silicone splint was
placed so that the wound was centered within the splint. An
immediate-bonding adhesive (KrazyGlueH) wasusedtofixthe splint
tothe skinfollowed byinterrupted sutures to stabilize its position and
Tegaderm (3M) was placed over the wounds. The animals were
housed individually. We tested the adhesive (Krazy GlueH)o nt h e
skin in mice prior to this experiment and did not observe any skin
irritation or allergic reaction.
Wound analysis
Digital photographs of wounds were taken at days 0, 3, 7, 10 and
14 days. Timetowound closurewas definedasthetime at which the
wound bed was completely re-epithelialized and filled with new
tissue. Wound area was measured by tracing the wound margin and
calculated using an image analysis program (NIH Image). The
investigators measuring samples were blinded to group and
treatment. The percentage of wound closure was calculated as:
(area of original wound 2 area of actual wound)/area of original
Table 2. Murine primers for Real-Time PCR
FORWARD REVERSE
Vascular endothelial growth factor-a VEGFa 59-AGAGCAACATCACCATGCAG-39 59-CAGTGAACGCTCCAGGATTT-39
Epidermal growth factor EGF 59-AGCTGTGTCTTCTTCACT-39 59-TGGGGTCACCTGCTTTAAC-39
keratinocyte growth factor KGF 59-CTTCCAATGAGGTCAGCAA-39 59-CCATAAATCAACAGGCAAAA-39
Insulin-like growth factor IGF 59-GGTGGTTTATGAATGGTT-39 59-AGGGTGTGTCTAATGGAG-39
heparin-binding EGF-like growth factor HB-EGF 59-AAAAGAAGAAGAAAGGAAAGGG-39 59-TGCAAGAGGGAGTACGGAA-39
Basic fibroblast growth factor bFGF 59-ATGATGACGACGACGATGA-39 59-CTACGGTTTGGTTTGGTGTTG-39
Transforming growth factor beta1 TGFb15 9-TGTTAAAACTGGCATCTGA-39 59-GTCTCTTAGGAAGTAGGT-39
stromal derived factor-1 SDF-1 59-GTCCTCTTGCTGTCCAGCTC-39 59-AGATGCTTGACGTTGGCTCT-39
stem cell factor SCF 59-TAATGTTCCCCGCTCTCT-39 59-TTTTGCTGTTTTTCTTTGCTTT-39
erythropoietin EPO 59-ACAGTCCCAGATACCAAA-39 59-GGCCTTGCCAAACTTCTATG-39
granulocyte colony stimulating factor G-CSF 59-ATCATTCTCTCCACTTCC-39 59-GTATTTACCCATCTCCTTCCCT-39
Thrombopoietin-1 TPO 59-ACCCCAGACTCCTAAATAAAC-39 59-CAGCAGAACAGGGATAGACAAA-39
Monocyte chemotactic protein-1 MCP-1 59-CCCGTAAATCTGAAGCTAA-39 59-CACACTGGTCACTCCTACAGAA-39
macrophage inflammatory protein1a MIP1a 59-CCAGTCCCTTTTCTGTTC-39 59-CTTGGTTGCAGAGTGTCAT-39
macrophage inflammatory protein1b MIP1b 59-ACGGGGGTCAATTCTAAG-39 59-GCCATTCCTGACTCCACA-39
monokine induced by gama interferon MIG 59-ACCAAAAGAAAAAGCAAAAGAG-39 59-CCTTGAACGACGACGACT-39
gama interferon-inducible protein-10 CXCL10 59-TGTCCTAGCTCTGTACTGT-39 59-AACTTAGAACTGACGAGCCT-39
glyceraldehyde-3-phosphate-dehydrogenase GAPDH 59-ATCATCCCTGCATCCACT-39 59-ATCCACGACGGACACATT-39
doi:10.1371/journal.pone.0001886.t002
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of the wound, so that the splinted hole was used to represent the
original wound size.Micewere sacrificed at7 and 14 dayswhenskin
samples including the wound and 4 mm of the surrounding skin
wereharvestedusing a 10 mmpunchbiopsy.Onewoundwhichwas
bisected into two pieces and one of them was used for histology. The
other wound was digested for FACS analysis.
Immunostaining and confocal microscopy
Tissue specimens were fixed in 3% freshly prepared PFA for 24 h
and embedded in OCT. Six-micron-thick tissue sections were pre-
incubated with sodium borohydride (1mg/ml in PBS) to reduce
auto-fluorescence and then incubated with an monoclonal antibody
against CD68 (Serotec) which was detected with a Cy3-conjugated
secondary antibody. Nuclei were stained with Hoechst. Sections
were examined with a Zeiss LSM 510 confocal microscope.
Statistical analysis
All values are expressed as mean6SD. Student’s paired t test
was performed for comparison of data of paired samples and
ANOVA was used for multiple group comparisons followed by
Friedman’s post test. A probability (P) value,0.05 was considered
significant.
Results
Cytokines released by BM-MSCs and fibroblasts
Real-Time PCR analysis of expression levels of growth factors
and chemokines in BM-MSCs and dermal fibroblasts treated
under hypoxic conditions revealed that BM-MSCs expressed
significantly greater amounts of several growth factors including
epidermal growth factor (EGF, 15 fold), keratinocyte growth factor
(KGF, 21 fold), insulin-like growth factor-1 (IGF-1, 49 fold),
vascular endothelial growth factor-a (VEGF-a, 19 fold), erythro-
poietin (EPO, 3 fold) and stromal cell-derived factor-1 (SDF-1, 3
fold), but lower amounts of transforming growth factor (TGF)-b1( -
3 fold) compared to dermal fibroblasts. Interestingly, angiopoietin
(Ang)1/Ang2 ratio was a greater in BM-MSCs (5.7) than in
fibroblasts (1.1) (Figure 1). Moreover, compared to dermal
fibroblasts, BM-MSCs expressed considerably greater amounts
of chemoattractants macrophage inflammatory protein (MIP)-1a
(1866 fold) and MIP-1b (7 fold) (Figure 1).
Figure 1. mRNA levels of cytokines and extracellular matrix molecules in BM-MSCs and fibroblasts. Total RNA extracted from BM-MSCs
(MSC) or dermal fibroblasts (FB) treated under hypoxic conditions was analyzed by Real-Time PCR for mRNA expression of genes as indicated in the
figure. Fold changes vs dermal fibroblasts are shown. Data are mean6SD; n=3; *P,0.05 vs FB. KGF, keratinocyte growth factor; HB-EGF, heparin-
binding EGF-like growth factor; TGFb1, Transforming growth factor-b1; Ang, angiopoietin; SDF1, stromal cell-derived factor-1; MIP, macrophage
inflammatory protein; SCF, stem cell factor; EPO, erythropoietin; TPO, thrombopoietin; G-CSF, granulocyte colony stimulating factor; MCP1, monocyte
chemotactic protein-1; MIG, monokine induced by gama interferon.
doi:10.1371/journal.pone.0001886.g001
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and dermal fibroblasts, we performed antibody-based protein
array analysis of fibroblast- or MSC-conditioned medium under
hypoxic or normoxic (data not shown) conditions, which reacted to
88 cytokines including 32 murine cytokines and 79 human
cytokines (23 cytokines were redundant, Figure 2A and Table 3).
Fifteen cytokines at differential expression levels were found; of
them 13 cytokines were apparently higher in BM-MSC-condi-
tioned medium including EGF, KGF, IGF-1, glial cell line-derived
neurotrophic factor (GDNF), platelet derived growth factor-BB
(PDGF-BB), VEGF-a, Ang-1, EPO, TPO, MIP-1, MIP-2, MCP-5
and soluble tumor necrosis factor receptor-1 (sTNF-R1), and two
cytokines were lower including IL6 and osteoprotegrin in BM-
MSC-conditioned medium, compared to fibroblast-conditioned
medium (Figure 2A and Table 3). Compared to normoxic
conditions, hypoxic treatments dramatically increased the release
of several cytokines including VEGF-a, Ang-1 and EPO by BM-
MSCs (Table 3). The amounts of IGF-1, KGF, PDGF-BB, EPO,
G-CSF and TPO in fibroblast- or MSC-conditioned medium were
further measured with ELISA and the results were consistent with
those of protein array analysis (Figure 2B). In all the cytokines
examined, similar expression patterns were found at mRNA and
protein levels (Figure 1 and 2).
Chemoattractive and mitogenic effects of MSC-
conditioned medium
Wound healing requires recruitment of cells into the wound
from surrounding tissues and blood and subsequent survival and
Figure 2. Protein levels of cytokines in BM-MSC-conditioned medium. (A) Antibody-based protein array analysis human dermal fibroblast
(FB)- or BM-MSC-conditioned medium under hypoxic conditions. Similar results were obtained from three independent experiments and results from
one of them are shown. The abbreviations are donated in Table 2. (B) ELISA measurement of cytokines in murine fibroblast- or BM-MSC- conditioned
medium under hypoxic conditions. Data are expressed as means6SD (n=3, *P,0.01). PDGF-BB, platelet-derived growth factor-BB. Other
abbreviations can be found in the legend for Figure 1.
doi:10.1371/journal.pone.0001886.g002
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Epithelial-neutrophil activating peptide ENA-78 ++ N/A N/A NC
Granulocyte colony-stimulating factor G-CSF ++ + /2 +/2 NC
Granulocyte-macrophage colony-stimulating factor GM-CSF +/2 +/2 ++ NC
Growth-related oncogene GRO ++ + N/A N/A NC
Growth-related oncogene a, CXCL1 GRO-a +/2 +/2 + +++ NC
CCL1 I-309 ++ N/A N/A NC
Interleukin-1a IL-1a ++ ++ N/A N/A NC
Interleukin-1b IL-1b ++ N/A N/A NC
Interleukin-2 IL-2 ++ + /2 +/2 NC
Interleukin-3 IL-3 ++ + /2 +/2 NC
Interleukin-4 IL-4 ++ ++ NC
Interleukin-5 IL-5 +/2 +/2 +/2 +/2 NC
Interleukin-6 IL-6 ++++ +++ +++ ++ NC
Interleukin-7 IL-7 +/2 +/2 N/A N/A NC
Interleukin-8 IL-8 ++ ++ N/A N/A NC
Interleukin-10 IL-10 ++ + /2 +/2 NC
Interleukin-12 IL-12 ++ + /2 +/2 NC
Interleukin-13 IL-13 +/2 +/2 ++ NC
Interleukin-15 IL-15 +/2 +/2 N/A N/A NC
Interferon c IFN-c +/2 +/2 +/2 +/2 NC
Monocyte chemoattractant protein-1, CCL2 MCP-1 ++ ++ +++ +++ NC
Monocyte chemoattractant protein-2, CCL8 MCP-2 +/2 +/2 N/A N/A NC
Monocyte chemoattractant protein-3, CCL7 MCP-3 +/2 +/2 N/A N/A NC
macrophage colony-stimulating factor M-CSF ++ N/A N/A NC
Macrophage Derived Chemokine MDC ++ N/A N/A NC
Monokine induced by IFN-Gamma, CXCL9 MIG +/2 +/2 N/A N/A NC
Macrophage inhibitory protein-1b, CCL4 MIP-1b ++ + N/A N/A NC
Macrophage inhibitory protein-1d MIP-1d ++ N/A N/A NC
Regulated on activation normal T cell-expressed and secreted, CCL5 RANTES ++ ++ NC
Stem cell factor SCF ++ + /2 +/2 NC
Stromal cell-derived factor 1 SDF-1 ++ N/A N/A NC
Thymus- and activation-related chemokine, CCL17 TARC +/2 +/2 ++ NC
Transforming Growth Factor-b1 TGF-b1 +/2 +/2 N/A N/A NC
Tumor necrosis factor-a TNF-a ++ + /2 +/2 NC
Tumor necrosis factor-b TNF-b ++ N/A N/A NC
Epidermal growth factor EGF +/2 + N/A N/A NC
Insulin-like growth factor-1 IGF-1 ++ + N/A N/A NC
Angiopoietin Ang +++ ++++ N/A N/A up
Oncostatin M OSM ++ + N/A N/A up
Thrombopoietin TPO ++ + ++ up
Vascular endothelial growth factor VEGF ++ ++++ ++ +++ up
Platelet derived growth factor-BB PDGF-BB +/2 + N/A N/A up
Leptin Leptin +/2 ++ /2 +/2 up
Brain derived neurotrophic factor BDNF ++ + N/A N/A up
B Lymphocyte Chemoattractant, CXCL13 BLC +/2 +/2 N/A N/A NC
CCL23 Ck b 8-1 +/2 +/2 N/A N/A NC
Eotaxin Eotaxin +/2 +/2 +/2 +/2 NC
Eotaxin-2 Eotaxin-2 +/2 +/2 N/A N/A NC
Eotaxin-3 Eotaxin-3 ++ N/A N/A down
Fibroblast growth factor-4 FGF-4 2 + N/A N/A NC
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conditioned medium from BM-MSCs grown in hypoxic conditions
to resemble normal wound healing environments exhibited
significantly greater chemoattractive effect on the migration of
CD14
+ monocytes (3 fold, Figure 3A), dermal keratinocytes (5 fold,
Figure 3B) and endothelial cells (3 fold, Figure 3D) and mitogenic
effect on the proliferation of keratinocytes (Figure 3C) and
endothelial cells (Figure 3E) in vitro, compared to similarly
prepared fibroblast-conditioned medium.
MSC-conditioned medium enhances wound healing
To examine whether BM-MSC-released factors could enhance
wound healing, we injected and topically applied 100 ml












Fibroblast growth factor-6 FGF-6 +/2 + N/A N/A NC
Fibroblast growth factor-7 FGF-7 +/2 + N/A N/A NC
Fibroblast growth factor-9 FGF-9 ++ + N/A N/A NC
FMS-related tyrosine kinase 3 ligand Flt-3 ligand +/2 + N/A N/A NC
Fractalkine Fractalkine ++ + N/A N/A up
granulocyte chemotactic protein-2 GCP-2 +/2 +/2 N/A N/A NC
Glial cell line-derived neurotrophic factor GDNF ++ + N/A N/A NC
hepatocyte growth factor HGF ++ +++ N/A N/A up
IGF binding protein-1 IGFBP-1 +/2 + N/A N/A NC
IGF binding protein-2 IGFBP-2 ++ ++ N/A N/A NC
IGF binding protein-3 IGFBP-3 ++ + N/A N/A NC
IGF binding protein-4 IGFBP-4 ++ + N/A N/A NC
interleukin 16 IL-16 +/2 +/2 N/A N/A NC
Interferon-inducible protein of 10 kDa, CXCL10 IP-10 ++ N/A N/A NC
Leukaemia inhibitory factor LIF ++ + N/A N/A NC
Tumor necrosis factor (ligand) super family, member 14 LIGHT ++ N/A N/A NC
CCL13 MCP-4 +/2 +/2 N/A N/A NC
Macrophage migration inhibitory factor MIF +/2 +/2 N/A N/A NC
macrophage inflammatory protein-3a MIP-3a +/2 + N/A N/A NC
Neutrophil-activating peptide-2 NAP-2 ++ + N/A N/A up
Neurotrophin 3 NT-3 ++ N/A N/A up
Neurotrophin 4 NT-4 ++ N/A N/A up
Osteoprotegrin OPTGRN ++++ ++ N/A N/A NC
CCL18 PARC ++ N/A N/A NC
Placenta growth factor PIGF ++ ++ N/A N/A NC
Transforming Growth Factor-b2 TGF-b2 ++ + N/A N/A NC
Transforming Growth Factor-b3 TGF-b3 ++ + N/A N/A NC
Metalloproteinase inhibitor-1 TIMP-1 ++++ ++++ + + NC
Metalloproteinase inhibitor-2 TIMP-2 ++++ ++++ N/A N/A NC
6Ckine, CCL21 6Ckine N/A N/A +/2 +/2 NC
Cutaneous T-cell-attracting chemokine, CCL27 CTACK N/A N/A ++ NC
IL12p70 IL12p70 N/A N/A ++ NC
Interleukin-17 IL17 N/A N/A +/2 +/2 NC
Monocyte chemoattractant protein-5, CCL12 MCP-5 N/A N/A ++ + NC
Macrophage inflammatory protein-1a MIP-1a N/A N/A ++ NC
Macrophage inflammatory protein-2 MIP-2 N/A N/A + +++ NC
Macrophage inflammatory protein-3b MIP-3b N/A N/A ++ NC
Soluble tumor necrosis factor receptor 1 sTNF-R1 N/A N/A ++ +++ NC
Human or murine dermal fibroblast- or BM-MSC-conditioned medium under hypoxic conditions for 24 h was analyzed with antibody-based protein array. The intensity
of each dot was measured. ‘‘2’’, not detected; +/2, weakly detected; + , ++++, intensity of positive detection; N/A, not tested; protein levels in medium under hypoxic
conditions are indicated as up, down or NC (no change) compared to normoxic conditions.
doi:10.1371/journal.pone.0001886.t003
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vehicle medium or fibroblast-conditioned medium were used as
controls. Careful measurements of wounds at 3, 7, 10 and 14 days
indicated that MSC-conditioned medium significantly accelerated
wound closure compared to vehicle control medium or fibroblast-
conditioned medium (Figure 4).
Effects of BM-MSC-conditioned medium on inflammation
and cell recruitment
To understand whether MSC-conditioned medium influence
the course of inflammation and cell recruitment, we examined
inflammatory cells and endothelial cells in the wound. We
harvested the entire wound along with a small fraction of the
Figure 3. Effects of BM-MSC-conditioned medium on cell migration and proliferation. (A) migration of CD14
+ monocytes. CD14
+
monocytes were isolated as described in ‘‘Methods’’ and equal numbers of the cells were loaded to the top chambers. Control (CTL) vehicle medium,
fibroblast (FB-M)- or BM-MSC (MSC-M)-conditioned medium at different concentrations were added to the bottom chambers. Cells migrated into the
bottom chambers were counted. Triple wells were used. Data shown represent mean6SD of 3 independent experiments (P,0.01). (B) Keratinocyte
migration. Equal numbers of murine dermal keratinocytes were added to the top chambers. Media in the bottom chambers were as indicated. Cells
migrated to the down-side of the filter were stained, photographed (6 fields per well) and counted. Triple wells were used for each treatment and
data shown represent mean6SD of 3 independent experiments (P,0.001). (C) Keratinocyte proliferation. 0.5610
5 murine dermal keratinocytes per
well were incubated with vehicle-M, FB-M, MSC-M or keratinocyte SFM supplemented with EGF (5 ng/ml, EGF) for different times and cell numbers
were counted. Triple wells were used for each treatment. Values shown represent mean6SD of 4 independent experiments (* P,0.01). (D) HUVEC
migration. The bottom chambers contained vehicle-M, FB-M or MSC-M at various dilutions. Cells migrated to the down-side of the filter were stained,
photographed (6 fields per well) and counted. Triple wells were used for each treatment and data shown represent mean6SD of three independent
experiments (*P,0.01 vs vehicle-M; #P,0.01 vs FB-M) (E) HUVEC proliferation. Equal numbers of HUVECs were grown in vehicle-, FB- or MSC-
conditioned basal endothelial growth medium (EGM-2) supplemented with 2% FBS or complete EGM-2 and incubated for 3 days. Cell numbers were
counted. Experiments were performed in triplicate wells (n=3, * P,0.001).
doi:10.1371/journal.pone.0001886.g003
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single cell suspension. Cell counts indicated cell number per
wound at day 7 (vehicle medium group 1.8160.24610
6; FB-M
group 1.9260.28610
6; MSC-M group 2.0460.27610
6,n = 5 )
and at day 14 (vehicle medium group 1.4160.16610
6, FB-M
group 1.5360.19610
6 and MSC-M group 1.5960.14610
6,
n=5,6). The cell suspension was analyzed on FACS after
staining with antibodies against CD45 for leucocytes, Gr-1 for
granulocytes, CD3 for T lymphocytes or CD4/80 for macro-
phages [22]. FACS analysis indicated that wounds treated with
MSC-conditioned medium at 7 and 14 days had significantly
increased numbers of CD4/80
+ macrophages (Figure 5A–C,
P,0.001), while the proportions of granulocytes and CD3 T cells
were unchanged, compared to wounds treated with vehicle
medium- or fibroblast-conditioned medium (Figure 5B&C). In
consistent with results in FACS analysis, immunohistochemical
assessment of wound sections for microphages with an antibody
against CD68, another marker for macrophages [22,23], showed
that wounds treated with MSC-conditioned medium had
increased abundance of CD68 positive cells compared to wounds
treated with vehicle medium or fibroblast-conditioned medium
(Figure 5D). To examine if MSC-conditioned medium enhanced
recruitment of endothelial cells and endothelial progenitor cells




+ cells. CD34 and c-kit are known to be expressed by
EPCs while CD34 and Flk-1 can be expressed by both EPCs and
endothelial cells [24]. FACS analysis showed that wounds treated
with MSC-conditioned medium had increased amounts of CD34
+,
c-kit
+ (at 1 and 2 weeks) and Flk-1
+ (at 1 week) cells compared to
vehicle medium- or fibroblast-conditioned medium-treated
wounds (Figure 5B&C, P,0.05).
Discussion
Chronic wounds are common diseases and difficult to heal. The
best treatments available can only achieve 50% wound closure
which is often temporary. In our previous study, we found that
implantation of BM-MSCs enhanced wound healing [25];
however, the mechanisms involved have not been fully under-
stood. In this study, we show that BM-MSC-conditioned medium
containing high levels of growth factors and chemokines enhances
wound healing in mice, implying a critical role of paracrine factors
in MSC-mediated enhanced wound healing.
Healing of full-thickness wounds involves migration of kerati-
nocytes, fibroblasts and endothelial cells to the wound bed
prepared with appropriate ECM molecule deposition and
proliferation of these cells. Immediately after injury, the wound
is hypoxic, which creates a chemoattractive environment to the
cells in adjacent tissues, circulating inflammatory cells, and
potentially circulating progenitor and stem cells [3]. Many growth
factors such as PDGF and VEGF have been known to be crucial
for the recruitment, survival and proliferation of these cells and
subsequent neovascularization [2,3]. In our previous study,
implantation of BM-MSCs was found to enhance wound healing
in normal and diabetic mice associated with increased angiogen-
esis [25]. However, BM-MSCs were found adjacent to the
vasculature was found but not in the vascular walls [25], suggesting
a paracrine effect of BM-MSCs in angiogenesis and wound
healing. In this study, we injected BM-MSC-conditioned medium
prepared under hypoxic conditions and achieved markedly
accelerated would closure, indicating that paracrine factors of
BM-MSCs alone could enhance wound healing.
BM-MSCs were found to secret certain cytokines in previous
studies, such as VEGF [26,27], bFGF, IL-6 and MCP-1 [26]. As
many cells could release these cytokines, the relative expression
levels and the values of BM-MSC-derived cytokines in wound
healing were unclear. In this study, we compared cytokines
released by BM-MSCs with those secreted by dermal fibroblasts
and their influences on wound healing. Fibroblasts are the major
stromal cells in the dermis and many other tissues. They are
known to appear in the wound healing process and release
numerous cytokines leading to fibrotic wound healing [2]. Our
data showed that BM-MSCs secreted differential levels of
numerous cytokines than dermal fibroblasts, such as significantly
greater amounts of EGF, KGF, IGF-1, VEGF-a, PDGF-BB, EPO
and TPO, but significantly lower amounts of IL6 and osteopro-
tegerin. Optimum healing of a wound requires a well-orchestrated
integration of many molecular events mediated by cytokines. EGF,
Figure 4. Effect of BM-MSC-conditioned medium on wound
closure. (A) Representative images of wounds before treatment or
7 days after treatment with vehicle control medium (vehicle-M),
concentrated fibroblast (FB-M)- or BM-MSC-conditioned medium
(MSC-M). (B) Measurement of wound sizes at different times (n=6 to
13, *P,0.05, **P,0.001).
doi:10.1371/journal.pone.0001886.g004
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to enhance normal wound healing [1,2,9]. Of these highly
expressed growth factors by BM-MSCs, IGF-1 is particularly
intriguing for two reasons. First, the expression of IGF-1 in BM-
MSCs is extremely high (49 fold higher at mRNA level and 22 fold
higher at protein level in the conditioned medium compared to
dermal fibroblasts); secondly, IGF-1 has recently been shown to
play a critical role in tissue regeneration [28–30]. Different from
BM-MSCs, dermal fibroblasts were found to release high levels of
IL6 and osteoprotegerin in this study. IL6 has long been known as
a potent pro-inflammatory cytokine [31]. Excessive secretion of
IL-6 is thought to contribute to the pathogenesis of many diseases
such as rheumatoid arthritis. Osteoprotegerin is involved in bone
metabolism [32], whose role in wound healing remains to be
Figure 5. Analysis of cells in wounds. (A) FACS analysis of cells derived from each wound indicated that wounds treated with concentrated BM-
MSC-conditioned medium (MSC-M) at 7 or 14 days had increased percentages of CD4/80 positive monocytes/macrophages compared to wounds
treated with vehicle control medium (vehicle-M) or concentrated fibroblast-conditioned medium (FB-M). (B&C) Percentages of cells in wound after
FACS analysis (n=5,6, *P,0.05). (D) Representative images of confocal microscopy of day 7 wounds treated with vehicle medium, concentrated
fibroblast- or BM-MSC-conditioned medium after immunostaining for CD68 (red). Nuclei were stained blue with Hoechst. scale bar, 20 mm.
doi:10.1371/journal.pone.0001886.g005
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our in vitro data in which BM-MSC-conditioned medium was
found to significantly enhance migration and proliferation of
keratinocytes and endothelial cells, while fibroblast-conditioned
medium only exhibited modest chemoattractive effect and little
mitogenic effect to these two cell types, and our in vivo data in
which BM-MSC-conditioned medium significantly accelerated
would closure while fibroblast-conditioned medium did not. Our
results suggest that BM-MSCs release high levels of growth factors
beneficial to normal wound healing.
In this study we showed that BM-MSCs secret high levels of
several chemokines such as MIP-1 and 2 and MCP-5, but lower
levels of IL6 than dermal fibroblasts. To examine whether BM-
MSC-conditioned medium could differentially recruit inflamma-
tory cells into the wound, we determined inflammatory cells in the
wound with FACS analysis and immunohistochemistry. Our data
showed that wounds treated with BM-MSC-conditioned medium
had significantly increased numbers of macrophages but un-
changed counts of granulocytes and CD3 T cells. This result is
consistent with our in vitro data in which BM-MSC-conditioned
medium was strongly chemoattractive to monocytes. MIP and MCP
are major chemoattractants for monocytes/macrophages and play a
key role in macrophage infiltration during wound healing [33,34].
Tissue macrophages have been known to play a pivotal role in tissue
repair. Reduction in macrophage infiltration is associated with
significantly delayed wound healing [33,34], and application of
macrophage-activating substances or injection of additional macro-
phages into healing wounds could augment the repair response in
both normal and healing-impaired wounds [35,36].
Neovascularization is a crucial step in the wound healing
process [1,2,37]. The formation of new blood vessels is necessary
to sustain the newly formed granulation tissue and the survival of
keratinocytes. In our previous study, we found that wounds
received implantation of BM-MSCs had enhanced angiogenesis
[25]. In this study, we showed that BM-MSC-conditioned medium
exerted potent chemoattractive and mitogenic effects on endothe-
lial cells. And wounds treated with BM-MSC-conditioned medium
had increased numbers of cells positive for CD34, C-kit or Flk-1,
which are known to be markers for endothelial lineage cells,
suggesting increased recruitment of endothelial cells and endothe-
lial progenitor cells into the wound. This result is consistent with
our analysis to the BM-MSC-conditioned medium, which showed
high levels of VEGF and SDF-1, known potent chemoattractants
to endothelial cells and endothelial progenitor cells [38,39].
Increased vasculature was found in BM-MSC-treated wounds
associated with elevated levels of VEGF-a and Ang-1 in our
previous study [25]. These data suggest that the high levels of pro-
angiogenic cytokines found in the BM-MSC-conditioned medium
such as VEGF-a, IGF-1, PDGF-BB and Ang-1 may enhance
proliferation of endothelial cells and neovascularization in the
wound.
Taken together, our data showed that BM-MSCs released high
levels of cytokines and chemokines which could enhance normal
wound healing, and BM-MSC-conditioned medium may promise
novel therapies to improve tissue repair.
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